欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/1344/001
药品名称Trabectedin STADA 0.25 mg powder for concentrate for solution for infusion
活性成分
    • TRABECTEDIN 0.25 mg
剂型Powder for concentrate for solution for infusion
上市许可持有人STADA Arzneimittel GmbH Muthgasse 36/2 1190 Wien, Austria
参考成员国 - 产品名称Austria (AT)
互认成员国 - 产品名称
    • Germany (DE)
      Trabectedin STADA 0,25 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
    • Belgium (BE)
    • Luxembourg (LU)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
      Trabectedin Stada
    • Hungary (HU)
      Trabectedin Stada 0,25 mg por oldatos infúzióhoz való koncentrátumhoz
    • Romania (RO)
      Trabectedina Stada 0,25 mg pulbere pentru concentrat pentru soluţie perfuzabilă
许可日期2023/09/26
最近更新日期2024/04/11
药物ATC编码
    • L01CX01 trabectedin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase